Maravai Lifesciences Company Top Insiders

MRVI Stock  USD 3.22  0.17  5.57%   
Maravai Lifesciences employs about 580 people. The company is managed by 17 executives with a total tenure of roughly 1354 years, averaging almost 79.0 years of service per executive, having 34.12 employees per reported executive. Assessment of Maravai Lifesciences' management performance can provide insight into the firm performance.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Maravai Lifesciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.0161) % which means that it has lost $0.0161 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4293) %, meaning that it created substantial loss on money invested by shareholders. Maravai Lifesciences' management efficiency ratios could be used to measure how well Maravai Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities.

Maravai Lifesciences Workforce Comparison

Maravai Lifesciences Holdings is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 15,236. Maravai Lifesciences holds roughly 580 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.81) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.23.

Maravai Lifesciences Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Maravai Lifesciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Maravai Lifesciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Maravai Lifesciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Maravai Lifesciences Notable Stakeholders

A Maravai Lifesciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Maravai Lifesciences often face trade-offs trying to please all of them. Maravai Lifesciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Maravai Lifesciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Carl HullCoFounder ChairmanProfile
Robert MBAChairman BoardProfile
Andrew BurchPresident ProductionProfile
Kevin HerdeExecutive CFOProfile
Kevin CPAExecutive CFOProfile
Kurt OreshackGeneral VPProfile
Kurt JDGeneral VPProfile
Christine DolanExecutive TechnologiesProfile
Brian NeelChief ProductionProfile
Peter LeddyExecutive OfficerProfile
Christopher BenoitExecutive EnzymesProfile
Becky BuzzeoExecutive OfficerProfile
Kate BroderickChief OfficerProfile
Rebecca BuzzeoExecutive OfficerProfile
Debra HartDirector RelationsProfile
Doreen PippenVP MarketingProfile
William IIIChief OfficerProfile

About Maravai Lifesciences Management Performance

The success or failure of an entity such as Maravai Lifesciences often depends on how effective the management is. Maravai Lifesciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Maravai management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Maravai management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California. Maravai LifeSciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 470 people.

Maravai Lifesciences Workforce Analysis

Traditionally, organizations such as Maravai Lifesciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Maravai Lifesciences within its industry.

Maravai Lifesciences Manpower Efficiency

Return on Maravai Lifesciences Manpower

Revenue Per Employee498.2K
Revenue Per Executive17M
Net Loss Per Employee205.2K
Net Loss Per Executive7M
Working Capital Per Employee1.1M
Working Capital Per Executive36M

Complementary Tools for Maravai Stock analysis

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios